LC
FLXN

Lindbrook Capital’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Lindbrook Capital’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-66
Closed – – 2257
2021
Q3 		$0 Buy
+66
New +$411 ﹤0.01% 2059

Lindbrook Capital's FLXN Position: Q4 2021 in Review

Lindbrook Capital sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 66 shares.

Lindbrook Capital first reported a position in FLXN in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

  • Lindbrook Capital reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Lindbrook Capital sold 66 Flexion Therapeutics, Inc. shares in Q4 2021.
  • Lindbrook Capital first reported a position in Flexion Therapeutics, Inc. in Q3 2021 and held it in 1 quarter.
  • Lindbrook Capital's Flexion Therapeutics, Inc. position peaked at $0 in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Lindbrook Capital's 13F filing for Q4 2021, filed 18 Jan 2022.